Analyst action$RMD5:21 PM ET

Morgans lifts ResMed target price 1.3% to A$40.00

By BORSA NewsroomPublished Nov 2, 2026, 5:21 PM ESTUpdated Nov 2, 2026, 5:22 PM EST

Morgans raised its price target on ResMed's Australian-listed shares (RMD.AU) by 1.3% to A$40.00. The note did not include a rating change or the prior target. The revision is small and directly affects the Australian line.

Sentimentbullish 60

Bullish · 60 of 100

Impact20

low · stays off the top drivers

Confidence90%

high confidence · single wire

Eventdeveloping

v1 · alerted to followers

WHAT WE KNOW

Morgans raised the target price on RMD.AU to A$40.00.
The increase was 1.3%.
No rating change or prior target was disclosed.